Short-read–based RNA-seq data derived from tissues of Dominette were available in the GenBank database because her tissues have been a freely distributed resource for the research community. To complement and extend these data and to ensure that the tissues used for Iso-Seq were also represented by
Euthanasia
It can be voluntary, involuntary, or non-voluntary.
Voluntary euthanasia occurs when a person requests to have their life ended, while involuntary euthanasia occurs when a person is killed without their consent.
Non-voluntary euthanasia occurs when a person is unable to give consent, such as in the case of a person in a persistent vegetative state.
Euthanasia is a complex and sensitive topic with important ethical, legal, and medical considerations.
Researchers and clinicians must carefully evaluate the optimal protocols and products for euthanizing animals or humans, balancing the need to relieve suffering with the sanctity of life.
Most cited protocols related to «Euthanasia»
Short-read–based RNA-seq data derived from tissues of Dominette were available in the GenBank database because her tissues have been a freely distributed resource for the research community. To complement and extend these data and to ensure that the tissues used for Iso-Seq were also represented by
Most recents protocols related to «Euthanasia»
Example 16
The instant study was designed to test the efficacy in cotton rats of hMPV vaccines against a lethal challenge. mRNA vaccines encoding hMPV fusion protein were used. The mRNA polynucleotide encodes a full-length fusion protein and comprises the wild-type nucleotide sequence obtained from the hMPV A2a strain.
Cotton rats were immunized intramuscularly (IM) at week 0 and week 3 with the mRNA vaccines encoding hMPV fusion protein with either 2 μg or 10 μg doses for each immunization. The animals were then challenged with a lethal dose of hMPV in week 7 post initial immunization via IV, IM or ID. The endpoint was day 13 post infection, death or euthanasia. Viral titers in the noses and lungs of the cotton rats were measured. The results (
Further, the histopathology of the lungs of the cotton mice immunized and challenged showed no pathology associated with vaccine-enhanced disease (
Example 13
The instant study is designed to test the efficacy in cotton rats of candidate hMPV vaccines against a lethal challenge using an hMPV vaccine comprising mRNA encoding Fusion (F) glycoprotein, major surface glycoprotein G, or a combination of both antigens obtained from hMPV. Cotton rats are challenged with a lethal dose of the hMPV.
Animals are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) at week 0 and week 3 with candidate hMPV vaccines with and without adjuvant. Candidate vaccines are chemically modified or unmodified. The animals are then challenged with a lethal dose of hMPV on week 7 via IV, IM or ID. Endpoint is day 13 post infection, death or euthanasia. Animals displaying severe illness as determined by >30% weight loss, extreme lethargy or paralysis are euthanized. Body temperature and weight are assessed and recorded daily.
In experiments where a lipid nanoparticle (LNP) formulation is used, the formulation may include a cationic lipid, non-cationic lipid, PEG lipid and structural lipid in the ratios 50:10:1.5:38.5. The cationic lipid is DLin-KC2-DMA (50 mol %) or DLin-MC3-DMA (50 mol %), the non-cationic lipid is DSPC (10 mol %), the PEG lipid is PEG-DOMG (1.5 mol %) and the structural lipid is cholesterol (38.5 mol %), for example.
Example 18
The instant study is designed to test the efficacy in cotton rats of candidate PIV3 vaccines against a lethal challenge using a PIV3 vaccine comprising mRNA encoding hemagglutinin-neuraminidase or fusion protein (F or F0) obtained from PIV3. Cotton rats are challenged with a lethal dose of the PIV3.
Animals are immunized intravenously (IV), intramuscularly (IM), or intradermally (ID) at week 0 and week 3 with candidate PIV3 vaccines with and without adjuvant. Candidate vaccines are chemically modified or unmodified. The animals are then challenged with a lethal dose of PIV3 on week 7 via IV, IM or ID. Endpoint is day 13 post infection, death or euthanasia. Animals displaying severe illness as determined by >30% weight loss, extreme lethargy or paralysis are euthanized. Body temperature and weight are assessed and recorded daily.
In experiments where a lipid nanoparticle (LNP) formulation is used, the formulation may include a cationic lipid, non-cationic lipid, PEG lipid and structural lipid in the ratios 50:10:1.5:38.5. The cationic lipid is DLin-KC2-DMA (50 mol %) or DLin-MC3-DMA (50 mol %), the non-cationic lipid is DSPC (10 mol %), the PEG lipid is PEG-DOMG (1.5 mol %) and the structural lipid is cholesterol (38.5 mol %), for example.
Example 1
A dose of 50 mg/kg of lipopolysaccharide (LPS) corresponds to the “lethal dose for 50 percent kill” that kills half of the population within 24 hours. Mice were subjected to intraperitoneal injection of 50 mg/kg LPS in 1×PBS for a vehicle control, and when the mice showed the signs of the moribund state, such as impaired motility, labored breathing, or inability to maintain an upright position, the mice were sacrificed by CO2 euthanasia, and the point was recorded as a humane endpoint. (The signs of the moribund state: impaired mobility, inability to maintain upright position, prolonged lack of activity and labored breathing)
All animal studies were performed according to protocols approved by Kyungpook National University (permit No. 2019-0003) and under recommendations for the proper use and care of the specific pathogen-free housing facility at Kyungpook University.
Top products related to «Euthanasia»
More about "Euthanasia"
It can be voluntary, where the individual consents, involuntary, where consent is not given, or non-voluntary, where the individual is unable to provide consent, such as in the case of a person in a persistent vegetative state.
The topic of euthanasia is complex and sensitive, with important ethical, legal, and medical considerations.
Researchers and clinicians must carefully evaluate the optimal protocols and products for euthanizing animals or humans, balancing the need to relieve suffering with the sanctity of life.
In animal research, common euthanasia methods include carbon dioxide exposure, cervical dislocation, and anesthetic overdose.
Widely used rodent species include C57BL/6J mice, C57BL/6 mice, and Sprague-Dawley rats.
Researchers may utilize techniques like FBS (fetal bovine serum), RNAlater (RNA stabilization reagent), Calcein (live cell fluorescent dye), and Matrigel (extracellular matrix gel) in their studies.
The field of euthanasia is constantly evolving, with researchers and policymakers exploring the latest protocols and products to ensure the most humane and ethical practices.
PubCompare.ai's AI-driven research tools can help identify the optimal euthanasia methods, enhancing reproducibility and accuracy in your research.